ALKERMES reported $294.54M in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 184.98M 2.54M
Amgen AMGN:US $ 36522M 332M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Coherus Biosciences CHRS:US $ 196.04M 224.42M
Eli Lilly And LLY:US $ 16813.8M 305M
Heron Therapeutics HRTX:US $ 149.18M 0.05M
Horizon Pharma HZNP:US $ 2566.99M 1.75M
Intra Cellular Therapies ITCI:US $ 0M 0M
IONIS PHARMACEUT IONS:US $ 1253.13M 1M
JAZZ PHA JAZZ:US $ 6021M 2.87M
Marinus Pharmaceuticals MRNS:US $ 70.35M 0.42M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Otsuka Holdings 4578:JP Y 209034M 2839M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Revance Therapeutics RVNC:US $ 396.1M 53.64M
Teva Pharmaceutical Industries TEVA:US $ 22082M 835M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M